Definium Therapeutics Us, Inc.

This phase 3 study tests an oral medication called MM120 against a placebo in 245 adults with generalized anxiety disorder. The main goal is to see if MM120 reduces anxiety symptoms over 12 weeks, with an optional 40-week follow-up to check long-term safety and effects. Participa…

This study tests an oral medication called MM120 for adults with major depressive disorder. About 149 participants will receive either MM120 or a placebo for 12 weeks, followed by a 40-week period where everyone can get the active drug. The main goal is to see if MM120 reduces de…

This study tests an oral medication called MM120 against a placebo in 214 adults with generalized anxiety disorder. The first 12 weeks are double-blind (neither patients nor doctors know who gets the drug), followed by a 40-week period where everyone can receive MM120. The main g…